Characteristic | Stage | |||||||
---|---|---|---|---|---|---|---|---|
 | A | B | C1 | C2 | D1 | D2 | D3 | |
Definition | At risk | Progressive | Asymptomatic severe | Symptomatic severe | ||||
Severity | Normal to trivial | Mild | Moderate | Severe | ||||
Echocardiography | Â | Â | Â | |||||
 Morphology |  |  |  | |||||
  Leaflet | BAV, sclerosis | Calcified, fibro-thickening, commissure fusion | Severe calcified, fibro-thickening, commissure fusion | |||||
  Motion | Normal | Mild to moderate systolic motion reduction | Severely reduced opening | |||||
 AVA-CE (cm2) | - | 1.5–2.0 | 1.0–1.5 | ≤1.0 | ≤1.0 | ≤1.0 | ≤1.0a | ≤1.0 |
 Vmax (m/sec) | <2.0 | 2.0–2.9 | 3.0–3.9 | ≥4.0 | ≥4.0 | ≥4.0 | <4.0a | <4.0 |
 MSPG (mmHg) | - | <20 | 20–39 | ≥40 | ≥40 | ≥40 | <40 | <40 |
 AVAi (cm2) | - | ≥1.0 | 0.6–0.9 | <0.6 | ||||
 LV diastolic dysfunction | None | Early | Mild | Significant | Restrictive | |||
 LV hypertrophy | None | Mild | Mild | Significant | ↑RWT, ↓Cavity | |||
 LVEF | Normal | Normal | Normal | <50 | Normal | <50 | Normalb | |
 Flow-gradient | Normal | Normal | NF-HG | NF-HG | NF-HG | LF-LG | NF-LG/pLF-LG | |
Symptom | None | None | None | DOE, EI, cardinal symptomsc |